CRL EBITDA Margin
Charles River Laboratories · EBITDA Margin
CRL EBITDA Margin
Latest reported5.51%period ending
CRL TTM EBITDA Margin (27.38% → 5.51%)
TTM ebitda margin
High-resolution chart · PNG
CRL ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 5.5132% | |
| 7.2153% | |
| 10.2316% | |
| 12.8347% | |
| 13.1159% | |
| 13.5733% | |
| 14.3492% | |
| 24.3876% | |
| 24.6733% | |
| 24.5403% | |
| 24.9943% | |
| 25.3002% | |
| 25.1346% | |
| 25.2489% | |
| 24.8021% | |
| 23.0434% | |
| 23.6075% | |
| 23.6453% | |
| 23.1673% | |
| 24.6397% | |
| 25.9509% | |
| 26.2446% | |
| 26.2821% | |
| 24.2125% | |
| 21.8555% | |
| 20.8984% | |
| 21.4808% | |
| 20.3297% | |
| 21.1548% | |
| 21.9391% | |
| 22.3835% | |
| 22.5904% | |
| 22.9527% | |
| 23.5014% | |
| 24.6496% | |
| 24.6169% | |
| 24.0555% | |
| 23.3768% | |
| 22.4385% | |
| 22.3064% | |
| 22.5335% | |
| 23.4986% | |
| 22.4001% | |
| 22.0308% | |
| 21.8004% | |
| 21.0431% | |
| 22.0389% | |
| 21.6526% | |
| 22.1986% | |
| 21.9682% | |
| 21.9585% | |
| 22.1258% | |
| 21.1177% | |
| 21.5651% | |
| 21.634% | |
| 22.168% | |
| 22.2061% | |
| 22.7618% | |
| 22.796% | |
| -12.6123% | |
| -15.2324% | |
| -17.2166% | |
| -17.9489% | |
| 16.3983% | |
| 19.6794% | |
| 21.3436% | |
| 21.9818% | |
| -34.1802% | |
| -31.2917% | |
| -28.8167% | |
| -26.139% | |
| 25.9207% | |
| 26.0338% | |
| 25.7281% | |
| 25.6867% | |
| 25.9907% | |
| 25.9904% | |
| 26.0344% | |
| 13.3218% | |
| 12.6847% | |
| 13.3596% | |
| 13.1117% | |
| 25.3835% | |
| 26.025% | |
| 25.5334% | |
| 26.759% | |
| 27.1866% | |
| 28.6435% | |
| 28.2135% | |
| 27.804% | |
| 27.6467% | |
| 27.1796% | |
| 27.2005% | |
| 27.0193% | |
| 26.6832% | |
| 26.1823% | |
| 25.5599% | |
| 25.5412% | |
| 25.5269% | |
| 24.8115% |